Proposed Data Collections Submitted for Public Comment and Recommendations, 75155-75157 [2014-29503]

Download as PDF Federal Register / Vol. 79, No. 242 / Wednesday, December 17, 2014 / Notices Counterparty Credit Risk Schedule Significant additions would be made to the Counterparty Credit Risk Schedule in order to more adequately and accurately capture exposure information related to derivatives and securities financing transactions (‘‘SFTs’’). These additions would remediate deficiencies discovered in the current collection related to exposure, including a lack of information regarding collateral, asset types, and total exposure to a given counterparty, and have been carefully evaluated internally and vetted with respondents. The FDIC proposes: (1) Adding a subschedule that collects the derivative exposures at a legal-entity nettingagreement level for the top 25 noncentral clearing counterparty (‘‘nonCCP’’) and non-G–7 counterparties, as well as all CCPs and the G–7 counterparties, that includes a breakout of collateral into cash and non-cash, and exposures into 14 asset categories; (2) changing the current SFT sub-schedule to collect exposures and collateral separately at a counterparty legal-entity netting-agreement level for the top 25 non-CCP and non-G–7 counterparties, as well as all CCPs and the G–7 counterparties, and adding asset subcategories for a total of 30 specific asset types; (3) removing all columns with the institution specification of margin period of risk (‘‘MPOR’’) under the global market shocks from subschedules F.1.a through F.1.e and F.2; (4) removing the column LGD Derived from Unstressed PD on F.2; and (5) adding columns to worksheet F.1.e to collect both gross and net stressed and unstressed current exposure to central clearing counterparties. Burden Estimates The FDIC estimates the burden of this collection as follows: mstockstill on DSK4VPTVN1PROD with NOTICES Current Number of Respondents: 4. Annual Burden per Respondent: 1,040. Total Annual Burden: 4,160. Proposed Estimated Number of Respondents: 4. Annual Burden per Respondent: 1,040. Estimated Total Annual Burden: 4,160 hours. The FDIC recognizes that the Board has estimated 88,401 hours for bank holding companies to prepare the Summary, Macroscenario, Operational risk, Regulatory capital transitions, Regulatory capital instruments, and Counterparty credit risk schedules submitted for the FR Y–14A. The FDIC VerDate Sep<11>2014 19:49 Dec 16, 2014 Jkt 235001 believes that the systems covered institutions use to prepare the FR Y– 14A reporting templates will also be used to prepare the reporting templates described in this notice. Comments continue to be invited on: (a) Whether the collection of information is necessary for the proper performance of the functions of the FDIC, including whether the information has practical utility; (b) The accuracy of the FDIC’s estimate of the burden of the collection of information; (c) Ways to enhance the quality, utility, and clarity of the information to be collected; (d) Ways to minimize the burden of the collection on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) Estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Dated at Washington, DC, this 11th day of December. Robert E. Feldman, Executive Secretary, Federal Deposit Insurance Corporation. [FR Doc. 2014–29418 Filed 12–16–14; 8:45 am] BILLING CODE 6714–01–P 75155 (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than January 12, 2015. A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. Brookfield Financial Holdings, Inc., Brookfield, Illinois; to become a bank holding company by acquiring 100 percent of the voting shares of First National Bank of Brookfield, Brookfield, Illinois. B. Federal Reserve Bank of Minneapolis (Jacquelyn K. Brunmeier, Assistant Vice President) 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291: 1. Border Bancshares Inc., Greenbush, Minnesota; to acquire 100 percent of the voting shares of First Advantage Bank, Coon Rapids, Minnesota. 2. Park Financial Group, Inc., Minneapolis, Minnesota; to become a bank holding company by acquiring 100 percent of the voting shares of Park State Bank, Duluth, Minnesota. FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies Board of Governors of the Federal Reserve System, December 12, 2014. Margaret McCloskey Shanks, Deputy Secretary of the Board. [FR Doc. 2014–29521 Filed 12–16–14; 8:45 am] BILLING CODE 6210–01–P The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–15–0932] Proposed Data Collections Submitted for Public Comment and Recommendations The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. To request more information on the below proposed project or to obtain a copy of the information collection plan and instruments, call 404–639–7570 or send comments to Leroy A. Richardson, 1600 E:\FR\FM\17DEN1.SGM 17DEN1 75156 Federal Register / Vol. 79, No. 242 / Wednesday, December 17, 2014 / Notices Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments submitted in response to this notice will be summarized and/or included in the request for Office of Management and Budget (OMB) approval. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Written comments should be received within 60 days of this notice. Proposed Project Data Collection for Evaluation of Education, Communication, and Training Activities—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). medical exam technical instructions more accessible. Approval of this revision of the generic information collection will allow DGMQ continue to collect in an expedited manner information about the knowledge, attitudes, and behaviors of key audiences (such as refugees, immigrants, migrants, international travelers, travel industry partners, healthcare providers, non-profit agencies, customs brokers and forwarders, schools, state and local health departments) to help improve and inform these activities during both routine and emergency public health events. This generic OMB clearance will help DGMQ continue to refine these efforts in a timely manner, and will be especially valuable for communication activities that must occur quickly in response to public health emergencies. DGMQ staff will use a variety of data collection methods for this proposed project: Interviews, focus groups, surveys, and pre/post-tests. Depending on the research questions and audiences involved, data may be gathered inperson, by telephone, online, or using some combination of these formats. Data may be collected in quantitative and/or qualitative forms. Numerous audience variables will be assessed under the auspices of this generic OMB clearance. These include, but are not limited to, knowledge, attitudes, beliefs, behavioral intentions, practices, behaviors, skills, self-efficacy, and information needs and sources. Insights gained from evaluation research will assist in the development, refinement, implementation, and demonstration of outcomes and impact of communication, education, and training activities. DGMQ estimates that 17,500 respondents and 7,982 hours of burden will be involved in evaluation research activities each year. The information being collected will not impose a cost burden on the respondents beyond that associated with their time to provide the required data. Background and Brief Description The Centers for Disease Control and Prevention (CDC) Division of Global Migration and Quarantine (DGMQ) is requesting a revision of a currently approved generic clearance to conduct evaluation research. This will help CDC plan and implement health communication, education, and training activities to improve health and prevent the spread of disease. These activities include communicating with international travelers and other mobile populations, training healthcare providers, and educating public health departments and other federal partners. The information collection for which the revision is sought is in accordance with DGMQ’s mission to reduce morbidity and mortality among immigrants, refugees, travelers, expatriates, and other globally mobile populations, and to prevent the introduction, transmission, or spread of communicable diseases from foreign countries into the United States. This mission is supported by delegated legal authorities outlined in the Public Health Service (PHS) Act (42 U.S.C. 264) and in regulations that are codified in 42 Code of Federal Regulations (CFR) parts 70 and 71, and 34. Since receiving initial approval for this generic, CDC has conducted three information collections. These information collections were in support of an Evaluation of Adapted Health Education Materials for LEP Spanish Speakers and Indigenous Migrants; Evaluation of the TravAlert Electronic Messaging System; and, a project entitled Scan This: Effectiveness of Quick Response Codes for Engaging International Panel Physicians. In order, these projects evaluated materials designed for specific audiences to determine if CDC’s methods for communicating key public health messages were translated appropriately for low-English proficiency residents in the United States, were effective in reaching travelers in airports, and were useful in making CDC’s immigration ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents mstockstill on DSK4VPTVN1PROD with NOTICES Type of respondents Form name General Public .................................. Healthcare Professionals .................. General Public .................................. Healthcare Professionals .................. General Public .................................. Healthcare Professionals .................. General Public .................................. Healthcare Professionals Interviews General Public .................................. Focus Groups Screening form ......... Focus Groups Screening form ......... Focus Groups ................................... Focus Groups ................................... Interview Screening Form ................ Interview Screening Form ................ Interviews ......................................... Interviews ......................................... Survey Screening Forms ................. VerDate Sep<11>2014 19:49 Dec 16, 2014 Jkt 235001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Number of responses per respondent 1,050 450 525 225 700 300 350 150 5,250 E:\FR\FM\17DEN1.SGM 1 1 1 1 1 1 1 1 1 17DEN1 Average burden per response (in hours) 10/60 10/60 90/60 90/60 10/60 10/60 1 1 10/60 Total burden (in hours) 175 75 788 338 117 50 350 150 875 75157 Federal Register / Vol. 79, No. 242 / Wednesday, December 17, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of responses per respondent Number of respondents Average burden per response (in hours) Total burden (in hours) Type of respondents Form name Healthcare Professionals .................. General Public .................................. Healthcare Professionals .................. General Public .................................. Healthcare Professionals .................. Survey Screening Forms ................. Surveys ............................................ Surveys ............................................ Pre/Post Tests .................................. Pre/Post Tests .................................. 2,250 2,625 1,125 1,750 750 1 1 1 1 1 10/60 45/60 45/60 45/60 45/60 375 1,969 844 1,313 563 TOTAL ....................................... ........................................................... 17,500 ........................ ........................ 7,982 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–29503 Filed 12–16–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Office for State, Tribal, Local and Territorial Support (OSTLTS) Meeting mstockstill on DSK4VPTVN1PROD with NOTICES In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009, and September 23, 2004, Consultation and Coordination with Indian Tribal Governments, CDC/Agency for Toxic Substances and Disease Registry (ATSDR), announces the following meeting and Tribal Consultation Session: Name: Tribal Advisory Committee (TAC) Meeting and 12th Biannual Tribal Consultation Session Times and Dates: 8:00 a.m.–5:00 p.m., February 10, 2015 (TAC Meeting) 8:00 a.m.–5:00 p.m., February 11, 2015 (12th Biannual Tribal Consultation Session) Place: The TAC Meeting and Tribal Consultation Session will be held at CDC Headquarters, 1600 Clifton Road, NE., Global Communications Center, Auditorium B3, Atlanta, Georgia 30333. Status: The meetings are being hosted by CDC/ATSDR in-person only and are open to the public. Attendees must pre-register for the event by Friday, January 23, 2015, at the following link: https://www.cdc.gov/tribal/ meetings.html. Purpose: The purpose of these recurring meetings is to advance CDC/ATSDR support for and collaboration with tribes, and to improve the health of tribes through, including but not limited to, assisting in eliminating the health disparities faced by Indian Tribes, ensuring that access to critical health and human services and public health VerDate Sep<11>2014 19:49 Dec 16, 2014 Jkt 235001 services is maximized to advance or enhance the social, physical, and economic status of Indians; and promoting health equity for all Indian people and communities. To advance these goals, CDC/ATSDR conducts government-to-government consultations with elected tribal officials or their authorized representatives. Consultation is an enhanced form of communication that emphasizes trust, respect, and shared responsibility. It is an open and free exchange of information and opinion among parties that leads to mutual understanding and comprehension. Matters for Discussion: The TAC and CDC leaders will discuss the following public health issue topics: Native specimens, injury prevention and occupational safety, hepatitis C virus, tuberculosis, and communication and engagement with tribes; however, discussion is not limited to these topics. During the 12th Biannual Tribal Consultation Session, tribes and CDC leaders will engage in a listening session with CDC’s director and roundtable discussions with CDC senior leaders, and tribes will have an opportunity to present testimony on tribal health issues. Tribal leaders are encouraged to submit written testimony by January 23, 2015, to April R. Taylor, Public Health Analyst for the Tribal Support Unit, OSTLTS, via mail to 4770 Buford Highway NE., MS E–70, Atlanta, Georgia 30341 or email to TribalSupport@ cdc.gov. Depending on the time available, it may be necessary to limit the time of each presenter. The agenda is subject to change as priorities dictate. Information about the TAC, CDC’s Tribal Consultation Policy, and previous meetings can be found at the following web link: https://www.cdc.gov/tribal. Contact person for more information: April R. Taylor, Public Health Analyst, CDC/ OSTLTS, 4770 Buford Highway NE., MS E– 70, Atlanta, Georgia 30341; email: ARTaylor@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–29489 Filed 12–16–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Occupational Safety and Health Training Project Grants, PAR10– 288, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 6:00 p.m.–8:00 p.m., January 13, 2015 (Closed) 8:00 a.m.–8:00 p.m., January 14, 2015 (Closed) Place: Atlanta Airport Marriott, 4711 Best Road, Atlanta, Georgia 30337, Telephone: (404) 766–7900 Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Occupational Safety and Health Training Project Grants, PAR10–288, initial review.’’ Contact Person for More Information: Donald Blackman, Ph.D., Scientific Review Officer, CDC, 2400 Century Center Parkway, NE., 4th Floor, Room 4204, Mailstop E–74, Atlanta, Georgia 30345, Telephone: (404) 498–6185, DYB7@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the E:\FR\FM\17DEN1.SGM 17DEN1

Agencies

[Federal Register Volume 79, Number 242 (Wednesday, December 17, 2014)]
[Notices]
[Pages 75155-75157]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-29503]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-15-0932]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC), as part of 
its continuing effort to reduce public burden and maximize the utility 
of government information, invites the general public and other Federal 
agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. To request more information on the below 
proposed project or to obtain a copy of the information collection plan 
and instruments, call 404-639-7570 or send comments to Leroy A. 
Richardson, 1600

[[Page 75156]]

Clifton Road, MS-D74, Atlanta, GA 30333 or send an email to 
omb@cdc.gov.
    Comments submitted in response to this notice will be summarized 
and/or included in the request for Office of Management and Budget 
(OMB) approval. Comments are invited on: (a) Whether the proposed 
collection of information is necessary for the proper performance of 
the functions of the agency, including whether the information shall 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden of the proposed collection of information; (c) ways to 
enhance the quality, utility, and clarity of the information to be 
collected; (d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques or other forms of information technology; and (e) 
estimates of capital or start-up costs and costs of operation, 
maintenance, and purchase of services to provide information. Burden 
means the total time, effort, or financial resources expended by 
persons to generate, maintain, retain, disclose or provide information 
to or for a Federal agency. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information. Written comments should be received within 60 
days of this notice.

Proposed Project

    Data Collection for Evaluation of Education, Communication, and 
Training Activities--Revision--National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC) Division of 
Global Migration and Quarantine (DGMQ) is requesting a revision of a 
currently approved generic clearance to conduct evaluation research. 
This will help CDC plan and implement health communication, education, 
and training activities to improve health and prevent the spread of 
disease. These activities include communicating with international 
travelers and other mobile populations, training healthcare providers, 
and educating public health departments and other federal partners.
    The information collection for which the revision is sought is in 
accordance with DGMQ's mission to reduce morbidity and mortality among 
immigrants, refugees, travelers, expatriates, and other globally mobile 
populations, and to prevent the introduction, transmission, or spread 
of communicable diseases from foreign countries into the United States. 
This mission is supported by delegated legal authorities outlined in 
the Public Health Service (PHS) Act (42 U.S.C. 264) and in regulations 
that are codified in 42 Code of Federal Regulations (CFR) parts 70 and 
71, and 34.
    Since receiving initial approval for this generic, CDC has 
conducted three information collections. These information collections 
were in support of an Evaluation of Adapted Health Education Materials 
for LEP Spanish Speakers and Indigenous Migrants; Evaluation of the 
TravAlert Electronic Messaging System; and, a project entitled Scan 
This: Effectiveness of Quick Response Codes for Engaging International 
Panel Physicians. In order, these projects evaluated materials designed 
for specific audiences to determine if CDC's methods for communicating 
key public health messages were translated appropriately for low-
English proficiency residents in the United States, were effective in 
reaching travelers in airports, and were useful in making CDC's 
immigration medical exam technical instructions more accessible.
    Approval of this revision of the generic information collection 
will allow DGMQ continue to collect in an expedited manner information 
about the knowledge, attitudes, and behaviors of key audiences (such as 
refugees, immigrants, migrants, international travelers, travel 
industry partners, healthcare providers, non-profit agencies, customs 
brokers and forwarders, schools, state and local health departments) to 
help improve and inform these activities during both routine and 
emergency public health events. This generic OMB clearance will help 
DGMQ continue to refine these efforts in a timely manner, and will be 
especially valuable for communication activities that must occur 
quickly in response to public health emergencies.
    DGMQ staff will use a variety of data collection methods for this 
proposed project: Interviews, focus groups, surveys, and pre/post-
tests. Depending on the research questions and audiences involved, data 
may be gathered in-person, by telephone, online, or using some 
combination of these formats. Data may be collected in quantitative 
and/or qualitative forms. Numerous audience variables will be assessed 
under the auspices of this generic OMB clearance. These include, but 
are not limited to, knowledge, attitudes, beliefs, behavioral 
intentions, practices, behaviors, skills, self-efficacy, and 
information needs and sources. Insights gained from evaluation research 
will assist in the development, refinement, implementation, and 
demonstration of outcomes and impact of communication, education, and 
training activities.
    DGMQ estimates that 17,500 respondents and 7,982 hours of burden 
will be involved in evaluation research activities each year. The 
information being collected will not impose a cost burden on the 
respondents beyond that associated with their time to provide the 
required data.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of respondents           Form name       respondents    responses per   response  (in    (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
General Public................  Focus Groups               1,050               1           10/60             175
                                 Screening form.
Healthcare Professionals......  Focus Groups                 450               1           10/60              75
                                 Screening form.
General Public................  Focus Groups....             525               1           90/60             788
Healthcare Professionals......  Focus Groups....             225               1           90/60             338
General Public................  Interview                    700               1           10/60             117
                                 Screening Form.
Healthcare Professionals......  Interview                    300               1           10/60              50
                                 Screening Form.
General Public................  Interviews......             350               1               1             350
Healthcare Professionals        Interviews......             150               1               1             150
 Interviews.
General Public................  Survey Screening           5,250               1           10/60             875
                                 Forms.

[[Page 75157]]

 
Healthcare Professionals......  Survey Screening           2,250               1           10/60             375
                                 Forms.
General Public................  Surveys.........           2,625               1           45/60           1,969
Healthcare Professionals......  Surveys.........           1,125               1           45/60             844
General Public................  Pre/Post Tests..           1,750               1           45/60           1,313
Healthcare Professionals......  Pre/Post Tests..             750               1           45/60             563
                                                 ---------------------------------------------------------------
    TOTAL.....................  ................          17,500  ..............  ..............           7,982
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-29503 Filed 12-16-14; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.